Question: What is the composition of the IET (Immuno Embryo Therapy)?
Answer: Injection of preparation of the human placenta.
Question: Why of the placenta namely?
Answer: Of all human tissues, the placenta is the only tissue containing a high concentration of the immunoblocking-activity products.
Question: Is it a special placenta, and is it obtained in artificial deliveries?
Answer: Certainly not. It is obtained following physiological deliveries. But, of course, not every placenta would be suitable, and not the whole placenta is used, but only particular tissues thereof.
Question: And what is the mechanism of its action?
Answer: It is a kind of vaccine against blocking factors of tumorous genesis. It should be pointed out that not against cancer cells, but rather against their immunosuppressor proteins similar to those in pregnancy. Subcutaneous administration of such preparation induces generation of deblocking antibodies.
These antibodies, figuratively speaking, kind of ”disrobe” the malignant cells, thus making them vulnerable to the cytotoxic lymphocytes. This is merely a hypotheses, and not an only one. It is possible that antibodies suppress the factor of angiogenesis, preventing growth of blood vessels of the tumour.
Question: What is the procedure of preparing the preparation for immunoembryotherapy?
Answer: It was described in the book. Only adequate bacterial and viral control is essential herein (like in blood transfusion).
Question: Is individual selection of the preparation for each patient necessary?
Answer: It is advisable. But any placenta contains the factors inhibiting immunity in cancer. I point out, not immunity of the host, but immunity of the tumour.
Question: Should anticancer vaccines be used, and how many such vaccines are there in the world?
Answer: Scientists have long been carrying out the related researchwork, however no trustworthy results have been obtained as yet. The cancer cells turned out to be reliably protected. Therefore, it is necessary to first of all destroy their protective ”armour”, and only thereafter apply specific and nonspecific stimulators of immunity. The problem consists in the strategy of anticancer combat. It seems likely that irradiation and certain chemopreparations do disturb synthesis of protein in cancer cells, therefore it seems appropriate to use them along with IET.
Question: Does this suggestion have anything in common with the tissue therapy by the V.P. Filatov technique which was popular in the 50s?
Answer: There is nothing in common. According to the Filatov technique, the placenta was autoclaved for one hour at a temperature of 120° C, thus completely being voided of proteins. The Filatov’s teaching on biogenic stimulators (V.P. Filatov. Selected works in 4 volumes. Edited by the Ukrainian SSR Academy of Sciences, Kiev, 1961, Vol. 2) does not seem applicable to the IET theory, for in this case everything depends on the placental molecules.
Question: Have experimental studies of placental preparations been carried out?
Answer: Such studies were carried out in rabbits, on the Brown-Pierce tumour model. But the human placenta was used because of the lack of means for such work. The results of animal studies not always can be extrapolated to man. From the very beginning we obtained good results on the irremediably diseased people (the appropriate permission was obtained by the Presidium of the Scientific Council of the Health Ministry), and therefore we did not hurry up to increase the number of the patients, but instead carried out long-term follow-up of our patients.
Question: What is your attitude towards surgical treatment of cancer?
Answer: The tumour, whenever possible, must be radically removed. Surgery is known to have saved great many oncological patients. Even an incomplete removal of the tumorous mass does facilitate the further execution of the IET. Sometimes even surgery does ”deblock” cancer. Inoperable patients, as we could be convinced, do not respond to the IET.
Question: And what is your attitude towards chemotherapy of cancer?
Answer: It is difficult to answer in one word. But at the present level of development of medicine this is inevitable. The devil of it is that oncologists because of this trend turned out to be thinking less,besides, no effective measures aimed at protection of the body from chemotoxicosis have yet been elaborated.
Question: How long does the IET last?
Answer: Sometimes, one massive injection turns out sufficient, we began with that. However, our experience showed that the immediate and short-term result (even 5 years) is not always reliable.
Question: Can cancer be cured completely with the help of IET?
Answer: I would not like to give an unsubstantiated answer to this question. Here are some case studies.